Industry & Company News

Read the latest news and announcements from Facet Life Sciences. Stay informed about our innovations and industry engagements.

Did You Know – Q1 2024

DID YOU KNOW? Facet’s strategic and tactical regulatory affairs, statistics, regulatory writing, and commercialization experts lead small organizations to faster and more efficient product development, US registration, and com...

Read More

Go Team! – Q1 2024

We’re so proud of our team members’ achievements! DANA BLUE APPOINTED TO AMWA 2024 ANNUAL CONFERENCE COMMITTEE For the second year in a row, Dana Blue, Facet Strategic Program Champion has been asked to serve on the...

Read More

Industry Focus – Q1 2024

Industry Focus Chinese Biotech In the Spotlight Over the last decade, small, medium-sized, and even large biopharmaceutical companies have come to rely on inexpensive manufacturing and nonclinical product development support fr...

Read More

Spotlight On – Q1 2024

RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTS FACET HELPS SMALL ORGANIZATION HOLD SUCCESSFUL FDA MEETING Small organization reaches FDA agreement on BLA requirements for novel diagnostic in Type C meeting.  Facet often w...

Read More
Spotlight

Facet By The Numbers – Q4 2023

FACET BY THE NUMBERS Early-stage development highlights:  3 IND preparation and submissions for NCEs, 3 IND clearances; over 35 IND amendments (e.g., new protocols/amendments, CMC updates, nonclinical study reports, annual repo...

Read More

Spotlight On – Q4 2023

RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTS  FACET HELPS PHYSICIAN GET IND FULL HOLD LIFTED Facet successfully prepares Complete Response (CR) to Investigator IND full hold to allow PI to proceed into the clinic.  FDA ...

Read More
Go to Top